SKINOVATION PHARMACEUTICAL INCORPORATED: operating expenses

Name: SKINOVATION PHARMACEUTICAL INCORPORATED: operating expenses
Creator: SKINOVATION PHARMACEUTICAL INCORPORATED

Operating expenses for SKINOVATION PHARMACEUTICAL INCORPORATED. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All SKINOVATION PHARMACEUTICAL INCORPORATED financial histories

What this measure means

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Exact concept: us-gaap:OperatingExpenses. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Reading these values

This selected numerical history matches General and administrative expense for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Selected filing history

Operating expenses in original reported units, latest-filed observation per period
Period start	Period end	Value	Unit	Filed	Source filing
2023-01-01	2023-12-31	14,929	USD	2024-04-15	10-K · 0001554795-24-000101
2022-01-01	2022-12-31	14,059	USD	2024-04-15	10-K · 0001554795-24-000101
2021-01-01	2021-12-31	13,830	USD	2023-03-30	10-K · 0001554795-23-000098
2020-01-01	2020-12-31	13,525	USD	2022-03-23	10-K · 0001554795-22-000111
2019-01-01	2019-12-31	13,555	USD	2021-03-29	10-K · 0001554795-21-000093
2018-01-01	2018-12-31	13,415	USD	2020-07-10	10-K · 0001554795-20-000172
2017-01-01	2017-12-31	13,330	USD	2019-03-19	10-K · 0001554795-19-000063
2016-01-01	2016-12-31	14,525	USD	2018-03-23	10-K · 0001554795-18-000061
2015-01-01	2015-12-31	15,400	USD	2017-03-20	10-K · 0001554795-17-000099
2014-01-01	2014-12-31	17,540	USD	2016-03-23	10-K · 0001554795-16-000582
2013-01-01	2013-12-31	29,181	USD	2015-02-20	10-K · 0001554795-15-000068
2012-01-01	2012-12-31	33,330	USD	2014-03-28	10-K · 0001554795-14-000240
2011-01-01	2011-12-31	24,923	USD	2013-03-27	10-K · 0001548123-13-000077
2010-01-01	2010-12-31	6,719	USD	2012-03-30	10-K · 0001010412-12-000148

Related financial histories

Inspect the source

Entity: SKINOVATION PHARMACEUTICAL INCORPORATED / CIK 0001118072
Captured: 2026-09-21T17:18:22.262Z
SEC response SHA-256: 2a8f12373902fb089789064a50866081690b54ca91a66a8d71a686a973e9e781

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001118072.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))